Fluorochrome bone formation parametersBiomarker1 paper studies itAnimals1LatestAging and Disease·Dec 6Targeting Sclerostin and Dkk1 at Optimized Proportions of Low-Dose Antibody Achieves Similar Skeletal Benefits to Higher-Dose Sclerostin Targeting in the Mature Adult and Aged SkeletonExperiments in miceInterventionsPaper
Aging and Disease·Dec 6Targeting Sclerostin and Dkk1 at Optimized Proportions of Low-Dose Antibody Achieves Similar Skeletal Benefits to Higher-Dose Sclerostin Targeting in the Mature Adult and Aged SkeletonExperiments in miceInterventionsPaper